Automated Tests for Accurate Diagnosis
According to WHO estimates, the dengue virus infects 100 to 400 million people worldwide every year, and it is rapidly spreading. Dengue is common in more than 100 countries around the world, including Southeast Asia, Central and South America, Western Pacific, and Africa. Most recently has spread to other areas including Europe. Fifty percent of the world’s population live in areas with a risk of dengue. To make it more complex, symptoms can be easily confused with other infection diseases such as malaria, chikungunya, Zika or yellow fever. Accurate confirmation of dengue diagnosis is essential to optimize patient management.
The VIDAS® Dengue panel includes the 3 serological tests recommended by international guidelines1 for accurate and early diagnosis, allowing fast and accurate confirmation or exclusion of dengue infection, supporting optimized patient management and response.
3 markers to cover the largest detection window
With VIDAS® Dengue NS1 Ag, VIDAS® Anti-Dengue IgM and VIDAS® Anti-Dengue IgG, we are proud to offer the 3 markers recommended by International Guidelines to cover the largest detection window for early diagnosis.
